• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Arkansas Biosciennces

Arkansas Biosciences

  • About ABI
  • Related Research Sites
  • Annual Reports

About ABI

Background | Administration | Board of Directors

Background

The vision for the Arkansas Biosciences Institute (ABI) emerged during a statewide planning process for use of the state’s share of the 1998 nationwide tobacco settlement.

Health care leaders across the state spoke out in favor of dedicating a portion of the tobacco settlement funds to innovative research that could help reduce or prevent smoking-related illnesses.

The voters eventually endorsed the proposed Tobacco Settlement Proceeds Act of 2000 by 64 percent in a referendum in November 2000. The Arkansas General Assembly enacted the provisions of that proposal as Acts 1569 through 1580 of 2001. Part of that legislation established the Arkansas Biosciences Institute (ABI) as a consortium of five research institutions: Arkansas Children’s Hospital (ACH); Arkansas State University (ASU); the University of Arkansas Division of Agriculture; the University of Arkansas, Fayetteville (UAF); and the University of Arkansas for Medical Sciences (UAMS). The legislation designated the president of the University of Arkansas System to chair a board of directors for the institute, with the board to include the senior executive of each member institution as well as two members to be appointed by the Governor.

Back to Top

ABI Administration

Alan Tackett, Ph.D.
Director, Arkansas Biosciences Institute
Distinguished Professor of Biochemistry and Molecular Biology
Deputy Director, Winthrop P. Rockefeller Cancer Institute
Executive Associate Dean for Basic Research, College of Medicine
Scharlau Family Endowed Chair in Cancer Research

Sonet Weed, M.S.
ABI Executive Administrator
Executive Director of Research Administration
College of Medicine

Jimie M Jarry
Program Project Manager, Arkansas Biosciences Institute
4301 W. Markham, Slot 821
Little Rock, AR 72205
501-526-6810 (tel.)

ABI Partnering Institution Directors

The ABI Partnering Institution Directors have been appointed by the five-member institutions to provide guidance for ABI scientific research.

Margaret Sova McCabe, J.D.
Vice Chancellor for Research and Innovation
University of Arkansas, Fayetteville

J.F. Meullenet, Ph.D.
Senior Associate Vice President
University of Arkansas Division of Agriculture

Dan Voth, Ph.D.
Vice Chair for Research and Innovation
University of Arkansas for Medical Sciences

Travis Marsico, Ph.D.
Vice Provost for Research, Innovation and Discovery 
Arkansas State University

Tamara T. Perry, M.D.
Interim President, Arkansas Children’s Research Institute
Arkansas Children’s Hospital

Back to Top

Board of Directors

The Arkansas Biosciences Institute Board, established in accordance with the Act, held its first meeting in January, 2002. The ABI Board, which provides for overall program coordination and direction, meets quarterly and reviews ABI-supported research projects.

Retired U.S. Air Force Lt. Gen. Jay B. Silveria, President
University of Arkansas System, Chair

Marcy Doderer, President and CEO
Arkansas Children’s Hospital

Tucker Patterson, Ph.D, Interim Director
National Center for Toxicological Research

Deacue Fields, Ph.D., Vice President for Agriculture
University of Arkansas System

Charles Robinson, Ph.D., Chancellor
University of Arkansas, Fayetteville

C. Lowry Barnes, M.D., Chancellor
University of Arkansas for Medical Sciences

Robin Myers, Ph.D., Interim President
Arkansas State University System

Back to Top

Footer

Member Institutions

University of Arkansas for Medical Sciences logo
University of Arkansas Division of Agriculture logo
Arkansas Children's Research Institute logo
Arkansas State University logo
University of Arkansas logo


© 2026 · Arkansas Biosciences Institute